Xuerong Bio-Tech invests 10.2m yuan in cordyceps venture
Shanghai Xuerong Bio-Technology is establishing Chengdu Xuecao Biotechnology with Qinghai Chenxin Biotechnology and director Zheng Weidong. The venture has 20 million yuan registered capital and will focus on cordyceps research, cultivation and sales.
Xuerong's subsidiary will contribute 10.2 million yuan for a 51% stake, while Zheng will invest 2.8 million yuan. The move supports the company's multi-variety strategy and aims to reduce edible mushroom business costs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Shanghai Xuerong Bio-Technology publishes news
Free account required • Unsubscribe anytime